v3.26.1
Note 12. Stock Compensation Plans - Textuals (Details) - $ / shares
 3 Months Ended 9 Months Ended
Dec. 31, 2025
Sep. 30, 2025
Mar. 31, 2026
Nov. 17, 2023
Oct. 20, 2016
Non-Employee Directors Stock Compensation Deferral Plan          
Share-based Compensation Arrangement by Share-based Payment Award          
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized         1,000,000.0
2023 Equity Incentive Plan          
Share-based Compensation Arrangement by Share-based Payment Award          
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized       2,000,000.0  
Performance Shares | 2023 Equity Incentive Plan          
Share-based Compensation Arrangement by Share-based Payment Award          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period [1]   29,335      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value [1],[2]   $ 28.35      
Performance Shares | 2023 Equity Incentive Plan | Maximum          
Share-based Compensation Arrangement by Share-based Payment Award          
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage     125.00%    
Performance Shares | 2023 Equity Incentive Plan | Minimum          
Share-based Compensation Arrangement by Share-based Payment Award          
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage     0.00%    
Restricted Stock | 2023 Equity Incentive Plan          
Share-based Compensation Arrangement by Share-based Payment Award          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period [3]   169,851      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value [2],[3]   $ 28.35      
Restricted Stock | 2023 Equity Incentive Plan | Maximum          
Share-based Compensation Arrangement by Share-based Payment Award          
ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualLife     3 years    
PerformanceSharesMember-LT | 2023 Equity Incentive Plan          
Share-based Compensation Arrangement by Share-based Payment Award          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period [4]   153,212      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value [2],[4]   $ 36.41      
PerformanceSharesMember-LT | 2023 Equity Incentive Plan | Maximum          
Share-based Compensation Arrangement by Share-based Payment Award          
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage     200.00%    
PerformanceSharesMember-LT | 2023 Equity Incentive Plan | Minimum          
Share-based Compensation Arrangement by Share-based Payment Award          
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage     0.00%    
Unrestricted Shares | 2023 Equity Incentive Plan          
Share-based Compensation Arrangement by Share-based Payment Award          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period [5] 20,555        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value [5] $ 28.34        
Deferred Share Units Director Compensation | Non-Employee Directors Stock Compensation Deferral Plan          
Share-based Compensation Arrangement by Share-based Payment Award          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period [6] 16,232        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value [6] $ 28.34        
[1] Long-term performance share awards were granted to key employees. These annual performance share awards were approved by the Talent, Culture, and Compensation Committee of the Board. These awards granted in fiscal year 2026 will cliff vest at the third anniversary of the award date in fiscal year 2029.For these key employee awards, a number of shares will be issued to each participant based upon a combination of the Company’s profitability based on its operating income over the performance period as defined in the Company’s operating business plans for the applicable fiscal years and the Company’s growth based on a comparison of its three-year compounded annual growth rate (“CAGR”) with the Electronics Manufacturing Services Industry’s three-year CAGR. The number of shares issued could be zero if minimum thresholds are not met up to a maximum of 125% if results on both measures exceed targets under the formula.
[2] The grant date fair value is the weighted average stock price based on the dates of the grants for all grants, with the exception of the portion of the long-term performance shares based on rTSR, the fair value of which is determined by a Monte Carlo simulation completed by a third party.
[3] Restricted shares were granted to leadership team members and other key employees. These restricted shares were approved by the Talent, Culture, and Compensation Committee of the Board. The contractual life of the restricted shares is three years, with one-third of the interest in the restricted shares vested after year one of the grant, another one-third after year two of the grant, and the final one-third after year three of the grant. Restricted shares are expensed over the contractual vesting period as earned. If the employment of a holder of restricted shares terminates before the RSU has vested for any reason other than death, retirement, or disability, the restricted shares not yet vested will be forfeited.
(4)Unrestricted shares were awarded to non-employee members of the Board as compensation for the portion of their annual retainer fees resulting from their elections to be paid in unrestricted shares in lieu of cash payment or deferred share units. Director’s fees are expensed over the period that directors earn the compensation. Unrestricted shares do not have vesting periods, holding periods, restrictions on sales, or other restrictions.
(5)Deferred share units were awarded to non-employee members of the Board as compensation for the portion of their annual retainer fees resulting from their elections to receive deferred share units in lieu of cash payment or unrestricted shares. Director’s fees are expensed over the period that directors earn the compensation. Deferred share units are participating securities and are payable in common stock in a lump sum or installments in accordance with deferral elections upon a Director’s retirement or termination from the Board or death.
[4] Long-term performance shares were granted to leadership team members. These annual performance share awards were approved by the Talent, Culture, and Compensation Committee of the Board. The awards granted in fiscal year 2026 will cliff vest in fiscal year 2029.
Under these awards, a number of shares will be issued to each participant based upon a combination of the Company’s economic profit for fiscal years 2026, 2027, and 2028 as compared to the Board approved plan and the Company’s relative total shareholder return (rTSR) for the performance period as compared to a group of peer companies selected by the Talent, Culture, and Compensation Committee of the Board. The number of shares issued could be zero if minimum thresholds are not met up to a maximum of 200% if results on both measures exceed targets under the formula.
[5] Unrestricted shares were awarded to non-employee members of the Board as compensation for the portion of their annual retainer fees resulting from their elections to be paid in unrestricted shares in lieu of cash payment or deferred share units. Director’s fees are expensed over the period that directors earn the compensation. Unrestricted shares do not have vesting periods, holding periods, restrictions on sales, or other restrictions.
[6] Deferred share units were awarded to non-employee members of the Board as compensation for the portion of their annual retainer fees resulting from their elections to receive deferred share units in lieu of cash payment or unrestricted shares. Director’s fees are expensed over the period that directors earn the compensation. Deferred share units are participating securities and are payable in common stock in a lump sum or installments in accordance with deferral elections upon a Director’s retirement or termination from the Board or death.